Clinical Trial Update: Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

This Phase 4 trial compared two insulin regimens (insulin detemir with insulin aspart vs NPH insulin with human soluble insulin) with or without metformin in Ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Human soluble insulin (insulin human soluble)
• Insulin aspart (insulin aspart)
• Insulin detemir (insulin detemir)
• NPH insulin (insulin isophane)
• metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: TERMINATED | Results posted: 2013-06-17